Healthcare & Life Sciences Industry Updates

Google News – Digital Health External News

£20m Cambridge hub to use AI to improve drug development - Home | Digital Health

news.google.com · 20 Aug 2026

Google News – Medical Devices External News

Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - insideprecisionmedicine.com

news.google.com · 20 Aug 2026

Google News – Medical Devices External News

1.4 Recent developments in medicines and medical devices for cardiovascular indications - A. Irs (EMA CWP) - European Medicines Agency (EMA)

news.google.com · 20 Aug 2026

Google News – Medical Devices External News

U.S. Food and Drug Administration seeks comments on the regulation of generative AI‑enabled medical devices - Digital Watch Observatory

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Researchers looking into whether GLP-1 drugs can help slow aging - Yahoo

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer - Yahoo Finance

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

NRx Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET - Yahoo Finance

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Spatial biology in clinical trials - Drug Discovery News

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Beyond GLP-1s: Combination Therapy, New Hormones Reshape Obesity Treatment - Yale Medicine

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Amylyx’s $35m-acquired PBH drug meets endpoints in Phase III trial - Clinical Trials Arena

news.google.com · 20 Aug 2026

Google News – Clinical Trials External News

Adding a Radiopharmaceutical to Standard Therapy in mRCC Does Not Improve Skeletal Events - The ASCO Post

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Regeneron Pharmaceuticals stock hits 52-week high at 821.41 USD - Investing.com

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

Why Alnylam Pharmaceuticals (ALNY) Stock Is Up Today - quiverquant.com

news.google.com · 20 Aug 2026

Google News – Pharmaceuticals External News

SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky - PR Newswire

news.google.com · 20 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

£20m Cambridge hub to use AI to improve drug development - Home | Digital Health

Nearly All FDA-Cleared AI Medical Devices Lack Evidence of Patient Benefit - insideprecisionmedicine.com

1.4 Recent developments in medicines and medical devices for cardiovascular indications - A. Irs (EMA CWP) - European Medicines Agency (EMA)

U.S. Food and Drug Administration seeks comments on the regulation of generative AI‑enabled medical devices - Digital Watch Observatory

Researchers looking into whether GLP-1 drugs can help slow aging - Yahoo

Rhythm Pharmaceuticals Announces Appointment of Manher (AJ) Joshi as Chief Medical Officer - Yahoo Finance

NRx Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET - Yahoo Finance

Spatial biology in clinical trials - Drug Discovery News

Beyond GLP-1s: Combination Therapy, New Hormones Reshape Obesity Treatment - Yale Medicine

Amylyx’s $35m-acquired PBH drug meets endpoints in Phase III trial - Clinical Trials Arena

Adding a Radiopharmaceutical to Standard Therapy in mRCC Does Not Improve Skeletal Events - The ASCO Post

Regeneron Pharmaceuticals stock hits 52-week high at 821.41 USD - Investing.com

Why Alnylam Pharmaceuticals (ALNY) Stock Is Up Today - quiverquant.com

SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky - PR Newswire